Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Curcumin Dictates Divergent Fates for the Central Salt Bridges in Amyloid-β40 and Amyloid-β42.

Chandra B, Mithu VS, Bhowmik D, Das AK, Sahoo B, Maiti S, Madhu PK.

Biophys J. 2017 Apr 25;112(8):1597-1608. doi: 10.1016/j.bpj.2017.02.043.

PMID:
28445751
2.

High plasticity of axonal pathology in Alzheimer's disease mouse models.

Blazquez-Llorca L, Valero-Freitag S, Rodrigues EF, Merchán-Pérez Á, Rodríguez JR, Dorostkar MM, DeFelipe J, Herms J.

Acta Neuropathol Commun. 2017 Feb 7;5(1):14. doi: 10.1186/s40478-017-0415-y.

3.

Nutrition and AGE-ing: Focusing on Alzheimer's Disease.

Abate G, Marziano M, Rungratanawanich W, Memo M, Uberti D.

Oxid Med Cell Longev. 2017;2017:7039816. doi: 10.1155/2017/7039816. Epub 2017 Jan 12. Review.

4.

Vitamin E, Turmeric and Saffron in Treatment of Alzheimer's Disease.

Adalier N, Parker H.

Antioxidants (Basel). 2016 Oct 25;5(4). pii: E40. Review.

5.

Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?

Corbi G, Conti V, Davinelli S, Scapagnini G, Filippelli A, Ferrara N.

Front Pharmacol. 2016 Oct 13;7:364. eCollection 2016. Review.

6.

Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease.

Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Kandimalla R, Kuruva CS.

J Investig Med. 2016 Dec;64(8):1220-1234. Epub 2016 Aug 12.

7.

Redox-based therapeutics in neurodegenerative disease.

McBean GJ, López MG, Wallner FK.

Br J Pharmacol. 2017 Jun;174(12):1750-1770. doi: 10.1111/bph.13551. Epub 2016 Aug 25. Review.

PMID:
27477685
8.

The Potential of Curcumin in Treatment of Spinal Cord Injury.

Sanivarapu R, Vallabhaneni V, Verma V.

Neurol Res Int. 2016;2016:9468193. doi: 10.1155/2016/9468193. Epub 2016 May 19. Review.

9.

Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.

Ferreira N, Gonçalves NP, Saraiva MJ, Almeida MR.

Sci Rep. 2016 May 20;6:26623. doi: 10.1038/srep26623.

10.

Advances in development of fluorescent probes for detecting amyloid-β aggregates.

Xu MM, Ren WM, Tang XC, Hu YH, Zhang HY.

Acta Pharmacol Sin. 2016 Jun;37(6):719-30. doi: 10.1038/aps.2015.155. Epub 2016 Mar 21. Review.

11.

Curcumin Ameliorates the Reduction Effect of PGE2 on Fibrillar β-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial Cells.

He GL, Luo Z, Yang J, Shen TT, Chen Y, Yang XS.

PLoS One. 2016 Jan 29;11(1):e0147721. doi: 10.1371/journal.pone.0147721. eCollection 2016.

12.

Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging.

Shimojo M, Higuchi M, Suhara T, Sahara N.

Front Neurosci. 2015 Dec 22;9:482. doi: 10.3389/fnins.2015.00482. eCollection 2015. Review.

13.
14.

Curcumin prophylaxis mitigates the incidence of hypobaric hypoxia-induced altered ion channels expression and impaired tight junction proteins integrity in rat brain.

Sarada SK, Titto M, Himadri P, Saumya S, Vijayalakshmi V.

J Neuroinflammation. 2015 Jun 6;12:113. doi: 10.1186/s12974-015-0326-4.

15.

Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.

Patil R, Gangalum PR, Wagner S, Portilla-Arias J, Ding H, Rekechenetskiy A, Konda B, Inoue S, Black KL, Ljubimova JY, Holler E.

Macromol Biosci. 2015 Sep;15(9):1212-7. doi: 10.1002/mabi.201500062. Epub 2015 Jun 2.

16.

Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice.

Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK.

PLoS One. 2015 Jun 2;10(6):e0128510. doi: 10.1371/journal.pone.0128510. eCollection 2015.

17.
18.
19.

Intravital Microscopy Imaging Approaches for Image-Guided Drug Delivery Systems.

Kirui DK, Ferrari M.

Curr Drug Targets. 2015;16(6):528-41. Review.

Supplemental Content

Support Center